Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
Research & Development
Novo Nordisk A/S
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novo Nordisk A/S
CSE:NOVO B
|
Research & Development
-kr29.4B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-10%
|
|
H Lundbeck A/S
CSE:HLUN A
|
Research & Development
-kr3.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ALK-Abello A/S
CSE:ALK B
|
Research & Development
-kr607m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Research & Development?
Research & Development
-29.4B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Research & Development amounts to -29.4B DKK.
What is Novo Nordisk A/S's Research & Development growth rate?
Research & Development CAGR 10Y
-10%
Over the last year, the Research & Development growth was -35%. The average annual Research & Development growth rates for Novo Nordisk A/S have been -29% over the past three years , -17% over the past five years , and -10% over the past ten years .